Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT06290856
What this trial is testing

Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

Who this might be right for
Metastatic Colorectal CancerPancreas AdenocarcinomaCholangiocarcinoma
Oslo University Hospital 16
Testing effectiveness (Phase 2)Looking for participantsNCT07255664
What this trial is testing

A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

Who this might be right for
Metastatic Colorectal CancerProstate Cancer MetastaticProstate Cancer Locally Advanced
CuraCell TX AB 12
Early research (Phase 1)Ended earlyNCT01302405
What this trial is testing

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Prism Pharma Co., Ltd. 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06255379
What this trial is testing

Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastasis Colorectal CancerColon CancerRectal Cancer
Guangzhou University of Traditional Chinese Medicine 52
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Testing effectiveness (Phase 2)Ended earlyNCT03127098
What this trial is testing

QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer

Who this might be right for
Thyroid CancerColon CancerOvarian Cancer+3 more
NantCell, Inc. 3
Testing effectiveness (Phase 2)UnknownNCT03210064
What this trial is testing

Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Hui ting Xu，MD 42
Early research (Phase 1)Study completedNCT02188264
What this trial is testing

Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colorectal CarcinomaSolid NeoplasmStage IIIA Colorectal Cancer AJCC v7+4 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Looking for participantsNCT06126406
What this trial is testing

Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+5 more
Chongqing Precision Biotech Co., Ltd 60
Testing effectiveness (Phase 2)UnknownNCT06363552
What this trial is testing

SC-0191 in Subjects With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Tianshu Liu 36
Testing effectiveness (Phase 2)Looking for participantsNCT06934538
What this trial is testing

First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Unresectable Metastatic Colorectal CancerUnresectable Locally Advanced Colorectal Cancer
Brenus Pharma 90
Testing effectiveness (Phase 2)Study completedNCT00574171
What this trial is testing

Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma

Who this might be right for
Metastatic Colorectal Cancer
University of Wisconsin, Madison 29
Testing effectiveness (Phase 2)UnknownNCT05406206
What this trial is testing

Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy

Who this might be right for
Advanced Colorectal CarcinomaLiver Metastasis Colon Cancer
Peking University Cancer Hospital & Institute 27
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Early research (Phase 1)Looking for participantsNCT07094204
What this trial is testing

Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Who this might be right for
Solid TumorNon-Small-Cell Lung CancerPancreatic Ductal Adenocarcinoma+1 more
Astellas Pharma Inc 364
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06195670
What this trial is testing

Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC

Who this might be right for
CRCMetastatic Colorectal CancerMetastatic Colorectal Adenocarcinoma
Zhejiang Cancer Hospital 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT07801352
What this trial is testing

CapeOx Combined With Anti-PD1 Antibody Plus Dihydroartemisinin as Neoadjuvant or Conversion Therapy for Microsatellite Stable Locally Advanced and Metastatic Colorectal Cancer

Who this might be right for
Locally Advanced Colorectal CancerMetastatic Colorectal Cancer
Shanghai Changzheng Hospital 15
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Testing effectiveness (Phase 2)Ended earlyNCT01993472
What this trial is testing

Study of Andrographolides With or Without Capecitabine to Treat Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Gu Yanhong 308
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Next Page